Valerii P. Shevchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Valerii P. Shevchenko has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Igor Yu. Nagaev
Russian Academy of Sciences
3 shared publications - Nikolai Myasoedov
Kurchatov Institute
3 shared publications - Alexander I. Shaposhnikov
All-Russia Research Institute for Agricultural Microbiology, Saint-Petersburg 196608, Russia
1 shared publication - Andrey A. Belimov
All-Russia Research Institute for Agricultural Microbiology, Saint-Petersburg 196608, Russia
1 shared publication - Kostiantyn V. Shevchenko
Полтавський державний медичний університет
1 shared publication - L.A. Bondarenko
Сумський державний університет
1 shared publication
Latest Publications
- Open Access
- 29 February 2024
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 1,p. 52-57
Effectiveness of Family Tuberculosis Treatment
Knowledge about tuberculosis dates back to 4—5 thousand years BC. For a while, it seemed that the infection might soon be overcome. However, since the late 1980s, there has been a significant increase in the incidence and mortality of both pulmonary and extrapulmonary tuberculosis. In parallel to this, there has been an emergence and increase in the quantitative and qualitative resistance of mycobacteria to antibacterial drugs, especially the multidrug-resistant type, reaching 60—65 % among patients treated for 5—6 months. The effectiveness of chemotherapy for this type of tuberculosis in Ukraine does not exceed 40—45 %, which determines the urgency of the problem. Objective — to compare the effectiveness of treatment of patients — sources and family contacts of tuberculosis. Materials and methods. Under our observation there were 406 individuals with familial-type tuberculosis, who were divided into the comparison group (source of tuberculosis) — 207 people, and the main group (contacts) — 199 people. The examinations were conducted according to the established standards. Treatment followed the protocols of the Ministry of Health of Ukraine. Results and discussion. The sources of multidrug-resistant mycobacteria in the comparison group were found in 42.6 % of patients, and among the family contacts of tuberculosis — 39.4 % (p > 0.05), indicating a similar origin. Drug-sensitive forms of tuberculosis mycobacteria were detected in 20.0 % of the comparison group and 20.2 % in the main group. We failed to abacillate 27.8 % patients in the comparison group and 8.1 % in the main group, which is 3.5 times less (p < 0.001). Relapses within 2 years observation occurred in 16.4 % of convalescents in the comparison group and 9.0 % in the main group. Mortality rate of the comparison group is at 13.0 % and 8.5 % of the main group patients. Social rehabilitation of individuals capable of working in the comparison group occured in 16.5 %, and 24.6 % in the main group, which is 1.5 times more (p < 0.05). Conclusions. Therefore, the effectiveness of patient treatment in the main group significantly exceeded that of patients in the comparison group, confirming the importance of organizational measures in phthisiology.
- 29 February 2024
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 1,p. 52-57
Open AccessEffectiveness of Family Tuberculosis Treatment
Knowledge about tuberculosis dates back to 4—5 thousand years BC. For a while, it seemed that the infection might soon be overcome. However, since the late 1980s, there has been a significant increase in the incidence and mortality of both pulmonary and extrapulmonary tuberculosis. In parallel to this, there has been an emergence and increase in the quantitative and qualitative resistance of mycobacteria to antibacterial drugs, especially the multidrug-resistant type, reaching 60—65 % among patients treated for 5—6 months. The effectiveness of chemotherapy for this type of tuberculosis in Ukraine does not exceed 40—45 %, which determines the urgency of the problem. Objective — to compare the effectiveness of treatment of patients — sources and family contacts of tuberculosis. Materials and methods. Under our observation there were 406 individuals with familial-type tuberculosis, who were divided into the comparison group (source of tuberculosis) — 207 people, and the main group (contacts) — 199 people. The examinations were conducted according to the established standards. Treatment followed the protocols of the Ministry of Health of Ukraine. Results and discussion. The sources of multidrug-resistant mycobacteria in the comparison group were found in 42.6 % of patients, and among the family contacts of tuberculosis — 39.4 % (p > 0.05), indicating a similar origin. Drug-sensitive forms of tuberculosis mycobacteria were detected in 20.0 % of the comparison group and 20.2 % in the main group. We failed to abacillate 27.8 % patients in the comparison group and 8.1 % in the main group, which is 3.5 times less (p < 0.001). Relapses within 2 years observation occurred in 16.4 % of convalescents in the comparison group and 9.0 % in the main group. Mortality rate of the comparison group is at 13.0 % and 8.5 % of the main group patients. Social rehabilitation of individuals capable of working in the comparison group occured in 16.5 %, and 24.6 % in the main group, which is 1.5 times more (p < 0.05). Conclusions. Therefore, the effectiveness of patient treatment in the main group significantly exceeded that of patients in the comparison group, confirming the importance of organizational measures in phthisiology.
- 1 March 2020
- Published by Pleiades Publishing Ltd in Doklady Chemistry
- Vol. 491 (1) , 41-44
Comparative Study of the Abscisic Acid Metabolism Using Analogue Tritium-Labeled in the Cyclohexene or Side Moiety
A procedure was developed for introducing tritium into the side chain of the abscisic acid (ABA) molecule. The reaction was carried out in dioxane in the presence of the Lindlar catalyst. The yield of the labeled product was 70% and the molar radioactivity was 44 Ci/mol. The tritium-labeled abscisic acid analogue was found to be a growth substrate for soil bacteria that incorporate a radioactive label into cellular metabolites. The absorption of the label by bacteria from the side chain of abscisic acid is more than an order of magnitude higher than that for labeling in the cyclohexene moiety. The results indicate the existence of a previously unknown metabolism pathway of ABA in microorganisms.
- 1 March 2020
- Published by Pleiades Publishing Ltd in Doklady Chemistry
- Vol. 491 (1) , 41-44
Comparative Study of the Abscisic Acid Metabolism Using Analogue Tritium-Labeled in the Cyclohexene or Side Moiety
A procedure was developed for introducing tritium into the side chain of the abscisic acid (ABA) molecule. The reaction was carried out in dioxane in the presence of the Lindlar catalyst. The yield of the labeled product was 70% and the molar radioactivity was 44 Ci/mol. The tritium-labeled abscisic acid analogue was found to be a growth substrate for soil bacteria that incorporate a radioactive label into cellular metabolites. The absorption of the label by bacteria from the side chain of abscisic acid is more than an order of magnitude higher than that for labeling in the cyclohexene moiety. The results indicate the existence of a previously unknown metabolism pathway of ABA in microorganisms.
- 31 May 2003
- Published by Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii in Russian Chemical Reviews
- Vol. 72 (5) , 423-446
Solid-phase method for tritium labelling of biologically active compounds
- 31 May 2003
- Published by Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii in Russian Chemical Reviews
- Vol. 72 (5) , 423-446
Solid-phase method for tritium labelling of biologically active compounds
- 1 April 1994
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 34 (4) , 359-366
Enzymatic synthesis of tritium — labelled prostaglandin D2 and its conversion to other prostaglandins
The one‐stage enzymatic synthesis of tritium‐labelled prostaglandin D2 from labelled arachidonic acid was performed by using the enzyme system PGH‐synthetase/PGH‐PGD‐isomerase. By enzymatic and chemical transformation of [3H]PGD2 the following compounds were obtained: 15‐keto‐13,14‐dihydro‐[3PGD2, 9α,11β‐[3H]PGD2, 9‐deoxy‐Δ9‐[3H]‐PGD2 ([3H]PGJ2) and Δ12‐13,14‐dihydro‐[3H]PGJ2. It was found that L‐selectride is a more effective reducing agent than sodium borohydride in the synthesis of 9α,11β‐[3H]PGF2.
- 1 April 1994
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 34 (4) , 359-366
Enzymatic synthesis of tritium — labelled prostaglandin D2 and its conversion to other prostaglandins
The one‐stage enzymatic synthesis of tritium‐labelled prostaglandin D2 from labelled arachidonic acid was performed by using the enzyme system PGH‐synthetase/PGH‐PGD‐isomerase. By enzymatic and chemical transformation of [3H]PGD2 the following compounds were obtained: 15‐keto‐13,14‐dihydro‐[3PGD2, 9α,11β‐[3H]PGD2, 9‐deoxy‐Δ9‐[3H]‐PGD2 ([3H]PGJ2) and Δ12‐13,14‐dihydro‐[3H]PGJ2. It was found that L‐selectride is a more effective reducing agent than sodium borohydride in the synthesis of 9α,11β‐[3H]PGF2.